Neurocrine Biosciences Inc

Common Name
Neurocrine Biosciences
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,800
Ticker
NBIX
Exchange
NASDAQ/NGS
Description
Neurocrine Biosciences Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments for neurological and endocrine-related disorders. ...

Disclosures of Neurocrine Biosciences

Explore Neurocrine Biosciences's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Neurocrine Biosciences's official channels and fully traceable to its official company sources.

The table below lists all of Neurocrine Biosciences's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Corporate Responsibility Report (CRR)2025
CSR Report2024
Annual Report2024
Financial & Extra-Financial Disclosure2024
Financial & Extra-Financial Disclosure2023
Annual Report2023
CSR Report2023
10-K2022
ESG Report2022
10-K2021
10-K2020
Annual Report2020
ESG Report2020
10-K2019
10-K2018
10-K2017
10-K2016
10-K2015
10-K2014
10-K2013
10-K2012
10-K2011
10-K2010
10-K2009
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?